← Back to Screener
Idexx Laboratories Inc (IDXX)
Price$589.25
Favorite Metrics
Price vs S&P 500 (26W)-13.11%
Price vs S&P 500 (4W)-7.42%
Market Capitalization$46.80B
P/E Ratio (Annual)44.17x
All Metrics
P/CF (Annual)39.60x
Book Value / Share (Quarterly)$20.14
P/TBV (Annual)36.12x
Indicated Dividend (Annual)$0.00
Revenue Growth (3Y)8.52%
Cash Flow / Share (Quarterly)$13.09
Price vs S&P 500 (YTD)-17.04%
Gross Margin (TTM)61.80%
Net Profit Margin (TTM)24.62%
EPS (TTM)$13.08
10-Day Avg Trading Volume0.47M
EPS Excl Extra (TTM)$13.08
Revenue Growth (5Y)9.72%
EPS (Annual)$13.08
ROI (Annual)43.19%
Gross Margin (Annual)61.80%
Net Profit Margin (5Y Avg)22.76%
Cash / Share (Quarterly)$2.26
P/E Basic Excl Extra (TTM)44.17x
Revenue Growth QoQ (YoY)14.28%
EPS Growth (5Y)14.28%
P/E Normalized (Annual)44.17x
ROA (Last FY)31.62%
Revenue Growth TTM (YoY)10.42%
EBITD / Share (TTM)$18.58
ROE (5Y Avg)79.61%
Operating Margin (TTM)31.60%
Cash Flow / Share (Annual)$13.09
P/B Ratio29.15x
P/B Ratio (Quarterly)33.65x
Net Income / Employee (Annual)$0
EV / Revenue (TTM)11.03x
Net Interest Coverage (TTM)34.07x
ROA (TTM)31.91%
EPS Growth QoQ (YoY)17.78%
EV / EBITDA (TTM)31.54x
EPS Incl Extra (Annual)$13.08
Current Ratio (Annual)1.23x
Quick Ratio (Quarterly)0.85x
3-Month Avg Trading Volume0.51M
52-Week Price Return46.44%
EV / Free Cash Flow (Annual)45.49x
P/E Incl Extra (TTM)44.17x
Revenue / Employee (TTM)$0
Tangible BV / Share (Quarterly)$18.76
P/S Ratio (Annual)10.87x
Asset Turnover (Annual)1.28x
52-Week High$769.98
Operating Margin (5Y Avg)29.24%
EPS Excl Extra (Annual)$13.08
CapEx CAGR (5Y)5.08%
Tangible BV CAGR (5Y)20.88%
26-Week Price Return-4.37%
Quick Ratio (Annual)0.85x
13-Week Price Return-17.06%
Total Debt / Equity (Annual)0.53x
Current Ratio (Quarterly)1.23x
Enterprise Value$47,468.677
Revenue / Share Growth (5Y)11.22%
Asset Turnover (TTM)1.30x
Book Value / Share Growth (5Y)22.18%
Revenue / Employee (Annual)$0
Inventory Turnover (Annual)4.33x
Pretax Margin (Annual)30.77%
Cash / Share (Annual)$2.26
3-Month Return Std Dev30.44%
Gross Margin (5Y Avg)60.19%
Net Income / Employee (TTM)$0
EBITDA CAGR (5Y)13.79%
EBITDA Interim CAGR (5Y)11.07%
ROE (Last FY)65.99%
Net Interest Coverage (Annual)37.95x
EPS Basic Excl Extra (Annual)$13.08
P/FCF (TTM)44.85x
Receivables Turnover (TTM)7.40x
EV / Free Cash Flow (TTM)45.49x
Total Debt / Equity (Quarterly)0.53x
EPS Incl Extra (TTM)$13.08
Receivables Turnover (Annual)7.40x
ROI (TTM)42.61%
P/S Ratio (TTM)10.87x
Pretax Margin (5Y Avg)28.37%
Revenue / Share (Annual)$53.12
Tangible BV / Share (Annual)$18.76
Forward P/E40.61x
Free OCF CAGR (5Y)14.08%
Price vs S&P 500 (52W)11.35%
P/E Ratio (TTM)44.17x
EPS Growth TTM (YoY)22.64%
Year-to-Date Return-12.90%
5-Day Price Return2.66%
EPS Normalized (Annual)$13.08
ROA (5Y Avg)27.96%
Net Profit Margin (Annual)24.62%
Month-to-Date Return4.87%
Cash Flow / Share (TTM)$11.16
EBITD / Share (Annual)$18.63
EPS Growth (3Y)17.66%
Operating Margin (Annual)31.60%
LT Debt / Equity (Annual)0.23x
P/CF (TTM)39.60x
ROI (5Y Avg)38.97%
P/E Excl Extra (TTM)44.17x
LT Debt / Equity (Quarterly)0.23x
EPS Basic Excl Extra (TTM)$13.08
P/TBV (Quarterly)36.12x
P/B Ratio (Annual)33.65x
Inventory Turnover (TTM)4.33x
Pretax Margin (TTM)30.77%
Book Value / Share (Annual)$20.14
Price vs S&P 500 (13W)-19.93%
Net Margin Growth (5Y)2.76%
Beta1.65x
P/FCF (Annual)44.85x
Revenue / Share (TTM)$53.48
ROE (TTM)69.78%
52-Week Low$398.75
Analyst Recommendations
Jan 2026
Feb 2026
Mar 2026
Apr 2026
4.05
4.05
4.05
4.05
Industry Peers — In Vitro Diagnostics(17)
| Symbol | P/S Ratio (TTM) | Revenue Growth TTM (YoY) | Gross Margin (TTM) | EPS Growth (5Y) | Price |
|---|---|---|---|---|---|
IDXXIdexx Laboratories Inc | 10.87x | 10.42% | 61.80% | 14.28% | $589.25 |
LNTHLantheus Holdings, Inc | 3.54x | 0.50% | 61.10% | 40.71% | $83.82 |
NNNNAnbio Biotechnology Class A Ordinary Shares | 295.25x | -5.72% | 89.00% | — | $27.15 |
CLDXCelldex Therapeutics, Inc | 1753.49x | -77.98% | 17.65% | — | $34.55 |
NEOGNeogen Corp | 2.38x | -3.91% | 45.20% | — | $9.51 |
NTLAIntellia Therapeutics, Inc | 26.10x | 16.92% | — | — | $14.95 |
QDELQuidelOrtho Corporation Common Stock | 0.32x | -1.89% | 46.67% | — | $12.71 |
MYGNMyriad Genetics Inc | 0.58x | -1.56% | 69.93% | — | $5.08 |
ACHVAchieve Life Sciences, Inc. | 15.24x | -89.25% | — | — | $5.10 |
TKNOAlpha Teknova, Inc. Common Stock | 3.87x | 7.35% | 33.17% | — | $2.93 |
IMDXInsight Molecular Diagnostics Inc. Common Stock | 30.46x | 115.58% | 56.97% | — | $3.84 |
About
IDEXX Laboratories is a leading provider of diagnostic solutions and practice management software for veterinary and livestock producers. The company offers in-clinic diagnostic test kits, laboratory analyzers, reference laboratory services, and veterinary practice management software that enable disease detection and management. With approximately 35% of revenues derived outside the United States, IDEXX operates across both domestic and international veterinary markets.